How Amanda Rolat Is Turning Plant-Based Dog Food Into a Health Business

Amanda Rolat didn't set out to start a plant-based pet food company. She set out to fix her dog's allergies. That distinction, health first, ideology never, is what she argues separates Bramble from the wave of ethics-driven animal product alternatives that rode the plant-based hype cycle and largely washed out.

In this conversation, Rolat gets into how a vet nutritionist's suggestion to try tofu became a commercially viable product, why Royal Canin and Hill's have quietly been doing this for years without calling it vegan, and what it actually takes to raise $4.5M for a category that most investors don't yet know how to size.

She also talks about the pressure to expand too fast, the surprisingly warm culture of pet trade shows, and why her senior dogs — fewer teeth and all — are shaping Bramble's next chapter.

My own personal experience with my dogs, combined with my experience selling and explaining Bramble to consumers and investors. Deservedly or not, the plant-based hype has faded, leaving behind skepticism about the category’s long-term strength and size. This is especially so with respect to plant-based pet food.

This was deeply frustrating to me because I, too, shared doubts about ultra-processed dry vegan pet food, which led me to start Bramble. People assumed it was just vegan pet food for vegan pet owners, but Royal Canin and Hill’s have been using plant protein in their hypoallergenic lines and not marketing it as plant-based. One of my dogs needed a hypoallergenic food, so I hired a vet nutritionist to formulate something for me to cook at home, and she suggested tofu.

It worked so well for him, but there was nothing commercially available. I always saw this as a health product. The ethics and sustainability are added bonuses.